Working… Menu

A Study in Recurrent Glioblastoma (GB)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01582269
Recruitment Status : Active, not recruiting
First Posted : April 20, 2012
Last Update Posted : August 25, 2020
Information provided by (Responsible Party):
Eli Lilly and Company